Coskunseven Efekan, Onder Methiye, Kymionis George D, Diakonis Vasilios F, Arslan Ebru, Tsiklis Nikolaos, Bouzoukis Dimitrios I, Pallikaris Ioannis
Dunya Eye Hospital, Istanbul, Turkey.
Am J Ophthalmol. 2007 Sep;144(3):387-389. doi: 10.1016/j.ajo.2007.05.035. Epub 2007 Jul 19.
To evaluate the results of combined Intacs (Addition Technology, Fremont, California, USA) and posterior chamber toric implantable Collamer lens [ICLs] (Visian ICL; STAAR Surgical, Monrovia, California, USA) implantation in keratoconic patients with extreme myopia and irregular astigmatism.
Prospective, single-center, noncomparative, interventional, consecutive case series.
Three eyes of two consecutive highly myopic keratoconic patients who had undergone posterior chamber toric ICLs implantation after Intacs implantation. Implantation of posterior chamber toric ICLs was performed at intervals between six and 10 months after Intacs implantation. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), refraction, topographic findings, adverse events, and postoperative complications were noted.
No intraoperative or postoperative complications were observed. An improvement in UCVA and BSCVA was found after the Intacs and toric Visian ICL procedures in all eyes. All eyes were emmetropic within 1 diopter (D), whereas the mean manifest refractive spherical equivalent refraction reduced from -18.50 +/- 2.61 D (range, -16.75 to -21.50 D) to 0.42 D (range, plano to -0.75 D). The mean difference between preoperative and last follow-up UCVA and BSCA was a gain of 6.67 +/- 1.15 lines (range, gain of six to eight lines) and 4.33 +/- 2.52 lines (range, gain of two to seven lines), respectively.
Combined Intacs and posterior chamber toric phakic Visian ICL implantation in a two-step procedure is an effective method for correcting keratoconic patients with extreme myopia.
评估联合使用Intacs(美国加利福尼亚州弗里蒙特市Addition Technology公司)和后房型散光型可植入式Collamer人工晶状体[ICL](Visian ICL;美国加利福尼亚州蒙罗维亚市STAAR Surgical公司)植入术治疗高度近视合并不规则散光圆锥角膜患者的效果。
前瞻性、单中心、非对比性、干预性、连续病例系列研究。
对两名连续的高度近视圆锥角膜患者的三只眼睛进行研究,这些患者在植入Intacs后接受了后房型散光型ICL植入术。后房型散光型ICL植入术在Intacs植入术后6至10个月进行。记录未矫正视力(UCVA)、最佳眼镜矫正视力(BSCVA)、验光结果、地形图检查结果、不良事件及术后并发症。
未观察到术中或术后并发症。所有眼睛在Intacs和散光型Visian ICL手术术后UCVA和BSCVA均有改善。所有眼睛的屈光不正均在1屈光度(D)以内,而平均明显屈光球镜等效度从-18.50±2.61 D(范围,-16.75至-21.50 D)降至0.42 D(范围,平光至-0.75 D)。术前与最后一次随访时UCVA和BSCA的平均差值分别为提高6.67±1.15行(范围,提高6至8行)和4.33±2.52行(范围,提高2至7行)。
分两步联合进行Intacs和后房型散光型有晶状体眼Visian ICL植入术是矫正高度近视圆锥角膜患者的有效方法。